The Need for Pediatric Drug Development
- PMID: 28942898
- PMCID: PMC7942021
- DOI: 10.1016/j.jpeds.2017.08.011
The Need for Pediatric Drug Development
Keywords: BPCA; Institute for Advanced Clinical Trials for Children; International Neonatal Consortium; PREA; pediatric clinical trials; pediatric pharmacology.
Conflict of interest statement
The other authors declare no conflicts of interest.
Figures
Comment in
-
Characteristics and Changes of Pediatric Therapeutic Trials under the Best Pharmaceuticals for Children Act.J Pediatr. 2018 Jan;192:8-12. doi: 10.1016/j.jpeds.2017.08.048. Epub 2017 Oct 10. J Pediatr. 2018. PMID: 29029810 Free PMC article. No abstract available.
References
-
- Hirschfeld S, Ward RM. History of children and the development of regulations at the FDA In: Mulberg AE, Murphy MD, Dunne J, Mathis LL, eds. Pediatric Drug Development: Concepts and Applications (2nd ed) West Sussex, UK: John Wiley & Sons, Ltd; 2013:6–15.
-
- Sachs AN, Avant D, Lee CS, Rodriguez W, Murphy MD. Pediatric information in drug product labeling. Jama 2012;307:1914–5. - PubMed
-
- Gorman RL. The march toward rational therapeutics in children. Pediatr Infect Dis J 2003;22:1119–23. - PubMed
-
- Wax PM. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med 1995;122:456–61. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
